Japan Tissue Engineering Company., Ltd. is a medical biotechnology company. The Company develops regenerative medicine using tissue engineering technology. Japan Tissue Engineering also provides research support services.

Summary Of Financial Results For The Second Quarter 2025

Announcement Of Nhi Listing Of Autologous Cultured Epidermis Maintaining Melanocytes "Jacemin" For The Treatment Of Vitiligo

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Japan Tissue Engineering Co (7774 JP)

Summary Of Financial Results For The Second Quarter 2025

Announcement Of Nhi Listing Of Autologous Cultured Epidermis Maintaining Melanocytes "Jacemin" For The Treatment Of Vitiligo

Announcement On The Progress Of The Clinical Trial Of Allogeneic Cultured Epidermis Allo-Jace03

Summary Of Financial Results For The First Quarter 2025

Submission Of A Request Of Approval For Partial Changes To Autologous Cultured Cartilage Jacc

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)